Literature DB >> 29635349

Linking inflammation and cancer: the unexpected SYK world.

Juan Fueyo1,2, Marta M Alonso3, Brittany C Parker Kerrigan2, Candelaria Gomez-Manzano1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29635349      PMCID： PMC5892156          DOI： 10.1093/neuonc/noy036

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  13 in total

1.  SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.

Authors:  Gerald Moncayo; Michal Grzmil; Tatiana Smirnova; Pawel Zmarz; Roland M Huber; Debby Hynx; Hubertus Kohler; Yuhua Wang; Hans-Rudolf Hotz; Nancy E Hynes; Georg Keller; Stephan Frank; Adrian Merlo; Brian A Hemmings
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

Review 2.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Authors:  Mariya O Krisenko; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2014-11-04

3.  The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

Authors:  P J Coopman; M T Do; M Barth; E T Bowden; A J Hayes; E Basyuk; J K Blancato; P R Vezza; S W McLeskey; P H Mangeat; S C Mueller
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 4.  Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk.

Authors:  Clifford A Lowell
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 5.  Getting Syk: spleen tyrosine kinase as a therapeutic target.

Authors:  Robert L Geahlen
Journal:  Trends Pharmacol Sci       Date:  2014-06-26       Impact factor: 14.819

6.  EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4.

Authors:  Ruey-Hwang Chou; Ying-Nai Wang; Yi-Hsien Hsieh; Long-Yuan Li; Weiya Xia; Wei-Chao Chang; Ling-Chu Chang; Chien-Chia Cheng; Chien-Chen Lai; Jennifer L Hsu; Wei-Jung Chang; Shu-Ya Chiang; Hong-Jen Lee; Hsin-Wei Liao; Pei-Huan Chuang; Hui-Yu Chen; Hung-Ling Wang; Sheng-Chu Kuo; Chung-Hsuan Chen; Yung-Luen Yu; Mien-Chie Hung
Journal:  Dev Cell       Date:  2014-07-28       Impact factor: 12.270

Review 7.  The SYK tyrosine kinase: a crucial player in diverse biological functions.

Authors:  Attila Mócsai; Jürgen Ruland; Victor L J Tybulewicz
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

8.  MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture.

Authors:  Elad Katz; Mohamed H Lareef; John C Rassa; Shannon M Grande; Leslie B King; Jose Russo; Susan R Ross; John G Monroe
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

Review 9.  Syk inhibitors in clinical development for hematological malignancies.

Authors:  Delong Liu; Aleksandra Mamorska-Dyga
Journal:  J Hematol Oncol       Date:  2017-07-28       Impact factor: 17.388

10.  TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1.

Authors:  Mohammad B Hossain; Rehnuma Shifat; David G Johnson; Mark T Bedford; Konrad R Gabrusiewicz; Nahir Cortes-Santiago; Xuemei Luo; Zhimin Lu; Ravesanker Ezhilarasan; Erik P Sulman; Hong Jiang; Shawn S C Li; Frederick F Lang; Jessica Tyler; Mien-Chie Hung; Juan Fueyo; Candelaria Gomez-Manzano
Journal:  Sci Adv       Date:  2016-04-01       Impact factor: 14.136
View more
  7 in total

Review 1.  Immunotherapies targeting stimulatory pathways and beyond.

Authors:  Julian A Marin-Acevedo; ErinMarie O Kimbrough; Rami Manochakian; Yujie Zhao; Yanyan Lou
Journal:  J Hematol Oncol       Date:  2021-05-12       Impact factor: 17.388

Review 2.  Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.

Authors:  Aradhana Rani; Justin Stebbing; Georgios Giamas; John Murphy
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-24       Impact factor: 5.555

3.  FCGR1A Serves as a Novel Biomarker and Correlates With Immune Infiltration in Four Cancer Types.

Authors:  Ji-Li Xu; Yong Guo
Journal:  Front Mol Biosci       Date:  2020-12-03

4.  Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells.

Authors:  Shahinda S R Alsayed; Shichun Lun; Anders W Bailey; Amreena Suri; Chiang-Ching Huang; Mauro Mocerino; Alan Payne; Simone Treiger Sredni; William R Bishai; Hendra Gunosewoyo
Journal:  RSC Adv       Date:  2021-04-26       Impact factor: 3.361

5.  Tumor cell SYK expression modulates the tumor immune microenvironment composition in human cancer via TNF-α dependent signaling.

Authors:  Adam Aguirre-Ducler; Nicole Gianino; Franz Villarroel-Espindola; Shruti Desai; Daiwei Tang; Hongyu Zhao; Konstantinos Syrigos; William L Trepicchio; Karuppiah Kannan; Richard C Gregory; Kurt A Schalper
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

6.  Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma-COPD Overlap in vivo and in vitro.

Authors:  Shuyi Li; Yang Hui; Jiqiao Yuan; Ziqian Zhang; Xuyu Li; Nan Fang; Mingbao Lin; Qi Hou
Journal:  J Inflamm Res       Date:  2021-05-24

7.  Feedback Regulation of Syk by Protein Kinase C in Human Platelets.

Authors:  Stephanie Makhoul; Stephanie Dorschel; Stepan Gambaryan; Ulrich Walter; Kerstin Jurk
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.